Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier J H Pepin

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The AAPS Journal|April 24, 2024
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics ModelingXavier J H Pepin, Sandra Suarez-Sharp
Pharmaceutical Research|August 27, 2023
SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System ParametersXavier J H Pepin, Iain Grant, J Matthew Wood
Pharmaceutical Research|May 18, 2022
The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry PerspectivesOm Anand, Xavier J H Pepin, Vidula Kolhatkar, et al.
Pharmaceutical Research|August 24, 2022
Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space - Part I: AdultsXavier J H Pepin, Maria Hammarberg, Alexandra Mattinson, et al.
The AAPS Journal|June 18, 2021
Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect ModelsChristian Wagner, Filippos Kesisoglou, Xavier J H Pepin, et al.
Pharmaceutics|January 8, 2025
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk AssessmentXavier J H Pepin, Juliana Johansson Soares Medeiros, Livia Deris Prado, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2019
Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model inputXavier J H Pepin, Natalie J Sanderson, Alexander Blanazs, et al.
Molecular Pharmaceutics|July 21, 2016
Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release TabletsXavier J H Pepin, Talia R Flanagan, David J Holt, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 2, 2024
Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modelingXavier J H Pepin, Scott M Hynes, Hamim Zahir, et al.
The AAPS Journal|January 5, 2021
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out ApproachXavier J H Pepin, James E Huckle, Ravindra V Alluri, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The AAPS Journal|April 24, 2024
Effect of Food Composition on the PK of Isoniazid Quantitatively Explained Using Physiologically Based Biopharmaceutics ModelingXavier J H Pepin, Sandra Suarez-Sharp
Pharmaceutical Research|August 27, 2023
SubQ-Sim: A Subcutaneous Physiologically Based Biopharmaceutics Model. Part 1: The Injection and System ParametersXavier J H Pepin, Iain Grant, J Matthew Wood
Pharmaceutical Research|May 18, 2022
The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry PerspectivesOm Anand, Xavier J H Pepin, Vidula Kolhatkar, et al.
Pharmaceutical Research|August 24, 2022
Physiologically Based Biopharmaceutics Model for Selumetinib Food Effect Investigation and Capsule Dissolution Safe Space - Part I: AdultsXavier J H Pepin, Maria Hammarberg, Alexandra Mattinson, et al.
The AAPS Journal|June 18, 2021
Use of Physiologically Based Pharmacokinetic Modeling for Predicting Drug-Food Interactions: Recommendations for Improving Predictive Performance of Low Confidence Food Effect ModelsChristian Wagner, Filippos Kesisoglou, Xavier J H Pepin, et al.
Pharmaceutics|January 8, 2025
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk AssessmentXavier J H Pepin, Juliana Johansson Soares Medeiros, Livia Deris Prado, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2019
Bridging in vitro dissolution and in vivo exposure for acalabrutinib. Part I. Mechanistic modelling of drug product dissolution to derive a P-PSD for PBPK model inputXavier J H Pepin, Natalie J Sanderson, Alexander Blanazs, et al.
Molecular Pharmaceutics|July 21, 2016
Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release TabletsXavier J H Pepin, Talia R Flanagan, David J Holt, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 2, 2024
Understanding the mechanisms of food effect on omaveloxolone pharmacokinetics through physiologically based biopharmaceutics modelingXavier J H Pepin, Scott M Hynes, Hamim Zahir, et al.
The AAPS Journal|January 5, 2021
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out ApproachXavier J H Pepin, James E Huckle, Ravindra V Alluri, et al.
Pageof 2